Nuclear Regulatory Commission October 2005 – Federal Register Recent Federal Regulation Documents

The U.S. Nuclear Regulatory Commission (NRC) is issuing NUREG- 1833, ``Technical Bases for Revision to the License Renewal Guidance Documents.'' This document describes the technical bases for the revision of NUREG-1801, ``Generic Aging Lessons Learned (GALL) Report'' and NUREG-1800 ``Standard Review Plan for the Review of License Renewal Applications for Nuclear Power Plants'' (SRP-LR).

Over 5 years have elapsed since the U.S. Nuclear Regulatory Commission (NRC) implemented its revised Reactor Oversight Process (ROP). The NRC is currently soliciting comments from members of the public, licensees, and interest groups related to the implementation of the ROP. An electronic version of the survey questions may be obtained from https://www.nrc.gov/NRR/OVERSIGHT/ASSESS/rop2005survey.pdf. This solicitation will provide insights into the self-assessment process and a summary of the feedback will be included in the annual ROP self- assessment report to the Commission.

The NRC has recently submitted to OMB for review the following proposal for the collection of information under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a current valid OMB control number. 1. Type of submission, new, revision, or extension: Revision. 2. The title of the information collection: NRC Form 483, ``Registration Certificatein vitro Testing with Byproduct Material Under General License''. 3. The form number if applicable: NRC Form 483. 4. How often the collection is required: There is a one-time submittal of information to receive a validated copy of NRC Form 483 with an assigned registration number. In addition, any changes in the information reported on NRC Form 483 must be reported in writing to the Commission within 30 days after the effective date of such change. 5. Who will be required or asked to report: Any physician, veterinarian in the practice of veterinary medicine, clinical laboratory or hospital which desires a general license to receive, acquire, possess, transfer, or use specified units of byproduct material in certain in vitro clinical or laboratory tests. 6. An estimate of the number of responses: 364. 7. The estimated number of annual respondents: 364 (104 NRC licensees and 260 Agreement State licensees). 8. An estimate of the number of hours needed annually to complete the requirement or request: 42 hours (12 hours NRC licensees and 30 hours Agreement State licensees). 9. An indication of whether Section 3507(d), Public Law 104-13 applies: Not applicable. 10. Abstract: Section 31.11 of 10 CFR establishes a general license authorizing any physician, clinical laboratory, veterinarian in the practice of veterinary medicine, or hospital to possess certain small quantities of byproduct material for in vitro clinical or laboratory tests not involving the internal or external administration of the byproduct material or the radiation therefrom to human beings or animals. Possession of byproduct material under 10 CFR 31.11 is not authorized until the physician, clinical laboratory, veterinarian in the practice of veterinary medicine, or hospital has filed NRC Form 483 and received from the Commission a validated copy of NRC Form 483 with a registration number. A copy of the final supporting statement may be viewed free of charge at the NRC Public Document Room, One White Flint North, 11555 Rockville Pike, Room O-1 F23, Rockville, MD 20852. OMB clearance requests are available at the NRC worldwide Web site: https:// www.nrc.gov/public-involve/doc-comment/omb/. The document will be available on the NRC home page site for 60 days after the signature date of this notice. Comments and questions should be directed to the OMB reviewer listed below by November 4, 2005. Comments received after this date will be considered if it is practical to do so, but assurance of consideration cannot be given to comments received after this date.

The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 25 and 26, 2005. A sample of agenda items to be discussed during the public sessions includes: (1) Discussion of the Energy policy Act of 2005, which provides for NRC regulation of accelerator- produced radioactive material and discrete sources of Ra-226; (2) Status of Specialty Board applications for NRC recognition; (3) Electronic signature in written directives; (4) Revision of NRC Form 313A; (5) RIS on dose control and assessment; (6) Review of the medical events definition commission paper. To review the agenda, see https:// www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact, via e- mail mss@nrc.gov. Purpose: Discuss issues related to 10 CFR 35, Medical Use of Byproduct Material. Date and Time for Closed Session Meeting: October 25, 2005, from 8 a.m. to 11 a.m. This session will be closed so that NRC staff can brief the ACMUI on discussing information relating solely to internal personnel rules. Dates and Times for Public Meetings: October 25, 2005, from 11 a.m. to 5 p.m.; and October 26, 2005, from 8 a.m. to 5 p.m. Address for Public Meetings: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2B3, 11545 Rockville Pike, Rockville, MD 20852-2738.